首页> 外国专利> IL-12 Composition for treating hepatic cancer comprising mesenchymal stem cell transfected with IL-12 expressing vector and the treatment methods using the same

IL-12 Composition for treating hepatic cancer comprising mesenchymal stem cell transfected with IL-12 expressing vector and the treatment methods using the same

机译:包含经IL-12表达载体转染的间充质干细胞的治疗肝癌的IL-12组合物及其使用方法

摘要

The present invention relates to a composition for treating liver cancer and a method for treating liver cancer in a mammal, which comprises mesenchymal stem cells transduced with an adenovirus vector expressing IL-12, wherein the expression of IL-12 is increased from the mesenchymal stem cells The present invention provides a composition for treating liver cancer comprising mesenchymal stem cells transfected with an adenovirus vector expressing IL-12 in combination with radiation therapy to enhance anti-cancer immunological activity in liver cancer cells. Induces apoptotic effects, so it has less side effects than conventional chemotherapy, and can further enhance the efficacy of radiotherapy.
机译:本发明涉及在哺乳动物中治疗肝癌的组合物和治疗肝癌的方法,其包含用表达IL-12的腺病毒载体转导的间充质干细胞,其中IL-12的表达从间充质干增加细胞本发明提供了用于治疗肝癌的组合物,其包括用表达IL-12的腺病毒载体转染的间充质干细胞与放射疗法相结合以增强肝癌细胞中的抗癌免疫活性。诱导凋亡作用,因此与常规化疗相比副作用更小,并且可以进一步提高放疗的疗效。

著录项

  • 公开/公告号KR101651171B1

    专利类型

  • 公开/公告日2016-08-25

    原文格式PDF

  • 申请/专利权人 연세대학교 산학협력단;

    申请/专利号KR20140064327

  • 发明设计人 성진실;

    申请日2014-05-28

  • 分类号A61K35/12;A61P35;

  • 国家 KR

  • 入库时间 2022-08-21 14:12:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号